Opendata, web and dolomites

BREATHE

EasyFlow: New asthma monitor to enable the effective control of asthma

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "BREATHE" data sheet

The following table provides information about the project.

Coordinator
ANAXSYS TECHNOLOGY LIMITED 

Organization address
address: MED IC4 KEELE SCIENCE PARK
city: KEELE NEWCASTLE STAFFORDSHIRE
postcode: ST5 5NL
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.anaxsys.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ANAXSYS TECHNOLOGY LIMITED UK (KEELE NEWCASTLE STAFFORDSHIRE) coordinator 50˙000.00

Map

 Project objective

Asthma affects the quality of life of millions of sufferers globally and causes a huge economic burden each year; asthma treatment is estimated to cost €17.7bn and the cost of lost productivity €9.8bn. It is estimated that in Europe there are 30 million asthma sufferers and 15,000 will die each year from an asthma attack even though the drugs used to treat asthma are safe, effective and if used correctly, would prevent many of these deaths. Asthma attacks result from ineffective monitoring leading to inadequate doses of prescribed drugs and therefore poor control of symptoms. Monitoring is vital as asthmatics will often not notice a gradual worsening of symptoms and will not adjust their medication accordingly potentially leading to a severe attack. Peak flow meters are currently used by asthmatics to monitor symptoms on a regular basis but compliance is poor as they are difficult to use, particularly in the young or old, and the technique required can cause exacerbation of symptoms plus the output then requires interpretation. We have developed a prototype of our easy to use home monitoring device that uses normal tidal breathing to generate breath profiles that change as symptoms deteriorate. The device incorporates our patented sensor housed in the mouth piece, which captures the breath profiles, attached to a handheld screen to display the interpretation of the breath profiles using an easy to understand traffic light system. Patients can then easily see whether they need to increase their asthma medication to control their symptoms and avoid an asthma attack. This Phase 1 project will assess the feasibility of device development and commercialisation including the clinical and regulatory requirements for CE marking.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BREATHE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BREATHE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More